Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy

被引:8
|
作者
Yang, Xiaolin [1 ]
Zhang, Xiaoqing [1 ]
Shen, Kaifeng [1 ]
Wang, Zhongke [2 ]
Liu, Guolong [1 ]
Huang, Kaixuan [1 ]
He, Zeng [1 ]
Li, Yang [1 ]
Hou, Zhi [1 ]
Lv, Shengqing [1 ]
Zhang, Chunqing [1 ,3 ]
Yang, Hui [1 ,3 ]
Liu, Shiyong [1 ,3 ]
Ke, Yanyan [1 ]
机构
[1] Army Med Univ, Affiliated Hosp 2, Dept Neurosurg, Chongqing, Peoples R China
[2] Armed Police Hosp, Dept Neurosurg, Chongqing, Peoples R China
[3] Chongqing Inst Brain & Intelligence, Guangyang Bay Lab, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
cuproptosis; Fdx1; LIPT1; temporal lobe epilepsy; diagnostic indicator; immune microenvironment; HIPPOCAMPAL SCLEROSIS; CELL-DEATH; COPPER; MICE; DEFICIENCY; METABOLISM; INDUCE;
D O I
10.3389/fphar.2023.1033859
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Temporal lobe epilepsy (TLE) is the most common subtype of epilepsy in adults and is characterized by neuronal loss, gliosis, and sprouting mossy fibers in the hippocampus. But the mechanism underlying neuronal loss has not been fully elucidated. A new programmed cell death, cuproptosis, has recently been discovered; however, its role in TLE is not clear.Methods: We first investigated the copper ion concentration in the hippocampus tissue. Then, using the Sample dataset and E-MTAB-3123 dataset, we analyzed the features of 12 cuproptosis-related genes in TLEs and controls using the bioinformatics tools. Then, the expression of the key cuproptosis genes were confirmed using real-time PCR and immunohistochemical staining (IHC). Finally, the Enrichr database was used to screen the small molecules and drugs targeting key cuproptosis genes in TLE.Results: The Sample dataset displayed four differentially expressed cuproptosis-related genes (DECRGs; LIPT1, GLS, PDHA1, and CDKN2A) while the E-MTAB-3123 dataset revealed seven DECRGs (LIPT1, DLD, FDX1, GLS, PDHB, PDHA1, and DLAT). Remarkably, only LIPT1 was uniformly upregulated in both datasets. Additionally, these DECRGs are implicated in the TCA cycle and pyruvate metabolism-both crucial for cell cuproptosis-as well as various immune cell infiltrations, especially macrophages and T cells, in the TLE hippocampus. Interestingly, DECRGs were linked to most infiltrating immune cells during TLE's acute phase, but this association considerably weakened in the latent phase. In the chronic phase, DECRGs were connected with several T-cell subclasses. Moreover, LIPT1, FDX1, DLD, and PDHB were related to TLE identification. PCR and IHC further confirmed LIPT1 and FDX1's upregulation in TLE compared to controls. Finally, using the Enrichr database, we found that chlorzoxazone and piperlongumine inhibited cell cuproptosis by targeting LIPT1, FDX1, DLD, and PDHB.Conclusion: Our findings suggest that cuproptosis is directly related to TLE. The signature of cuproptosis-related genes presents new clues for exploring the roles of neuronal death in TLE. Furthermore, LIPT1 and FDX1 appear as potential targets of neuronal cuproptosis for controlling TLE's seizures and progression.
引用
收藏
页数:18
相关论文
共 50 条
  • [21] Expression Profiles of Cuproptosis-Related Genes Determine Distinct Subtypes of Pancreatic Ductal Adenocarcinoma
    Chen, Yusheng
    Zou, Xuan
    Ma, Mingjian
    Liu, Yu
    Wang, Ruijie
    Dai, Zhengjie
    Tashiheng, Yesiboli
    Yan, Yu
    Yu, Xianjun
    Wang, Xu
    Liu, Chen
    Lin, Xuan
    Cheng, He
    CURRENT ONCOLOGY, 2023, 30 (02) : 1648 - 1662
  • [22] The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma
    Yao, Kai
    Zhang, Rumeng
    Li, Liang
    Liu, Mingdong
    Feng, Shiyao
    Yan, Haixin
    Zhang, Zhihui
    Xie, Dongdong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] TIGD1 Function as a Potential Cuproptosis Regulator Following a Novel Cuproptosis-Related Gene Risk Signature in Colorectal Cancer
    Wu, Zhiwei
    Lin, Changwei
    Zhang, Fan
    Lu, Zhixing
    Wang, Yaohui
    Liu, Yang
    Zhou, Zhijiao
    Li, Liang
    Song, Liying
    CANCERS, 2023, 15 (08)
  • [24] A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
    Wang, Xiang-Xu
    Wu, Li-Hong
    Ji, Hongchen
    Liu, Qing-Qing
    Deng, Shi-Zhou
    Dou, Qiong-Yi
    Ai, Liping
    Pan, Wei
    Zhang, Hong-Mei
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [25] Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma
    Chen, Yuqiao
    Tang, Lu
    Huang, Wentao
    Zhang, Youyu
    Abisola, Fakolade Hannah
    Li, Linfeng
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [26] Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
    Li, Hanrong
    Jiang, Huiming
    Huang, Zhicheng
    Chen, Zhilin
    Chen, Nanhui
    AGING-US, 2023, 15 (16): : 8325 - 8344
  • [27] Cinobufagin treatments suppress tumor growth by enhancing the expression of cuproptosis-related genes in liver cancer
    Amelimojarad, Mandana
    Amelimojarad, Melika
    Shariati, Parvin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, 398 (02) : 1575 - 1582
  • [28] Machine learning screening for Parkinson's disease-related cuproptosis-related typing development and validation and exploration of personalized drugs for cuproptosis genes
    Wu, Ji
    Qin, Chengjian
    Cai, Yuankun
    Zhou, Jiabin
    Xu, Dongyuan
    Lei, Yu
    Fang, Guoxing
    Chai, Songshan
    Xiong, Nanxiang
    ANNALS OF TRANSLATIONAL MEDICINE, 2023,
  • [29] A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma
    Xie, Yusai
    Zhang, Wei
    Sun, Jia
    Sun, Lingyan
    Meng, Fanjie
    Yu, Huiying
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [30] Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma
    Chen, Siliang
    Zhang, Shuxin
    Yuan, Yunbo
    Wang, Zhihao
    Li, Junhong
    Li, Tengfei
    Zuo, Mingrong
    Feng, Wentao
    Chen, Mina
    Liu, Yanhui
    FRONTIERS IN PHARMACOLOGY, 2022, 13